Alpha-9 Oncology
@a9oncology.com
Through peptide engineering and iterative design, Alpha9 Oncology creates highly selective, potent radiopharmaceuticals for cancer patients.
Alpha-9 Oncology's Company Logos
Alpha-9 Oncology's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#E04E35
Cinnabar
224, 78, 53
9, 73, 54
0, 65, 76, 12
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#29303D
Ebony Clay
41, 48, 61
219, 20, 20
33, 21, 0, 76
About Alpha-9 Oncology
Alpha9 Oncology is a leading brand in the development of highly selective and potent radiopharmaceuticals for cancer patients. Through peptide engineering and a bespoke, iterative approach to radiotherapeutic design, they create engineered molecules and a robust pipeline of radiopharmaceuticals to address solid and hematologic malignancies. With a team backed by top-tier investors and decades of expertise in developing targeted treatment for cancer, they are industry leaders in this specialized field.
Their recent strategic agreements and scientific advancements underscore their commitment to advancing the field of radiopharmaceuticals. Alpha9 Oncology is at the forefront of the fight against cancer, with a focus on capital efficient and rapid development to bring highly effective radiopharmaceuticals to the clinic. Located in Vancouver and Boston, their work is paving the way for new, groundbreaking approaches to cancer therapy, making a significant impact in the lives of patients worldwide.
Company type
Privately Held
Year founded
2018
Company size
11-50 employees
